GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » Huapont Life Science Co Ltd (SZSE:002004) » Definitions » Change In Receivables

Huapont Life Science Co (SZSE:002004) Change In Receivables : ¥0 Mil (TTM As of Sep. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Huapont Life Science Co Change In Receivables?

Huapont Life Science Co's change in receivables for the quarter that ended in Sep. 2024 was ¥0 Mil. It means Huapont Life Science Co's Accounts Receivable stayed the same from Jun. 2024 to Sep. 2024 .

Huapont Life Science Co's change in receivables for the fiscal year that ended in Dec. 2023 was ¥-588 Mil. It means Huapont Life Science Co's Accounts Receivable increased by ¥588 Mil from Dec. 2022 to Dec. 2023 .

Huapont Life Science Co's Accounts Receivable for the quarter that ended in Sep. 2024 was ¥2,366 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Huapont Life Science Co's Days Sales Outstanding for the three months ended in Sep. 2024 was 72.26.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Huapont Life Science Co's liquidation value for the three months ended in Sep. 2024 was ¥-7,416 Mil.


Huapont Life Science Co Change In Receivables Historical Data

The historical data trend for Huapont Life Science Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Huapont Life Science Co Change In Receivables Chart

Huapont Life Science Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only -29.71 -128.78 -1,039.69 59.61 -587.98

Huapont Life Science Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Huapont Life Science Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Huapont Life Science Co  (SZSE:002004) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Huapont Life Science Co's Days Sales Outstanding for the quarter that ended in Sep. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=2365.963/2987.794*91
=72.26

2. In Ben Graham's calculation of liquidation value, Huapont Life Science Co's accounts receivable are only considered to be worth 75% of book value:

Huapont Life Science Co's liquidation value for the quarter that ended in Sep. 2024 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=4235.602-14608.121+0.75 * 2365.963+0.5 * 2363.782
=-7,416

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Huapont Life Science Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Huapont Life Science Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Huapont Life Science Co Business Description

Traded in Other Exchanges
N/A
Address
No. 69, Renhe Xingguang Avenue, Yubei District, Chongqing, CHN, 401121
Huapont Life Science Co Ltd is a China-based company engaged in the manufacturing and distribution of pharmaceutical products. In addition, the company is also engaged in the agrochemical business and medical business. The agrochemical department is mainly engaged in the research and development, production, sales, and technical services of pesticide intermediates, original drugs, and preparations.
Executives
Zhang Hai An Directors, executives
Wang Rong Director
Yu Jun Tian Director
Zhang Song Shan Directors, executives
Chen Zhi Securities Affairs Representative
Jiang Kang Wei Director
Lv Li Ming Director
Li Sheng Xue Director
Luo Da Lin Supervisors
Li Zhi Directors, executives
Tian Song Min Executives
Wu Bi Zhong Director
Yu Yun Jian Supervisors
Gu Chuan Wei Supervisors

Huapont Life Science Co Headlines

No Headlines